Clinical Trials: Lupus

Alabama

Birmingham; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Huntsville; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Arizona

Tucson; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

California

Los Angeles; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Los Angeles; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Los Angeles; UCB Clinical Trial Call Center
Study of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients With Active Disease

San Leandro; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

San Leandro; UCB Clinical Trial Call Center
Study of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients With Active Disease

Torrance ; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Upland; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Upland; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Colorado

Colorado Springs; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Denver; UCB Clinical Trial Call Center
Study of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients With Active Disease

Denver; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Florida

Aventura; UCB Clinical Trial Call Center
Study of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients With Active Disease

Miami; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Georgia

Atlanta; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Idaho

Boise; Covance
Lupus (SLE)

Boise; Covance
Lupus (SLE)

Illinois

Chicago; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Maryland

Baltimore; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Baltimore; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Chevy Chase; The Center for Rheumatology and Bone Research - Chevy Chase, MD
Do you have Lupus?

Laurel; The Center for Rheumatology and Bone Research - Laurel, MD
Do you have Lupus?

Rockville; The Center for Rheumatology and Bone Research - Rockville, MD
Do you have Lupus?

Wheaton; The Center for Rheumatology and Bone Research - Wheaton, MD
Do you have Lupus ?

New York

Brooklyn; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Lake Success; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Lake Success; Biomedical Research Alliance of New York
Systemic Lupus Erythematosus (SLE) - Adults

Lake Success; Biomedical Research Alliance of New York
LUPUS - Adults

Manhasset; Biomedical Research Alliance of New York
Lupus Nephritis - Adults and Minors

Manhasset; Biomedical Research Alliance of New York
Lupus- Adults

Manhasset; Biomedical Research Alliance of New York
Renal Disease- Systemic Lupus

Manhasset; Biomedical Research Alliance of New York
Lupus – SLE (SYSTEMIC LUPUS ERYTHEMATOSUS) - Adults

New York; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

New York; Biomedical Research Alliance of New York
Systemic Lupus Erythematosus (SLE) - Adults and minors

Rochester; AAIR Research Center
Have you been diagnosed with Lupus?

North Carolina

Chapel Hill; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Charlotte; UCB Clinical Trial Call Center
Study of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients With Active Disease

Durham; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Durham; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Ohio

Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Ovary Protection Medication Study for Childhood Onset Lupus (ages 21 and under).

Columbus; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Oklahoma

Oklahoma City; Bone & Joint Hospital Research Dept
Lupus

Oklahoma City; UCB Clinical Trial Call Center
Study of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients With Active Disease

Tulsa; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Pennsylvania

Philadelphia; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Pittsburgh; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

South Carolina

Charleston; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Charleston; UCB Clinical Trial Call Center
Study of Epratuzumab in Systemic Lupus Erythematosus

Texas

Dallas; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Dallas; UCB Clinical Trial Call Center
Study of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients With Active Disease

Dallas; Metroplex Clinical Research Center
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Rituximab in Subjects with ISN/RPS Class III or IV Lupus Nephritis

Virginia

Arlington; UCB Clinical Trial Call Center
Study of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients With Active Disease

Washington, DC

Washington; The Center for Rheumatology and Bone Research - Washington, DC
Do you have Lupus?

International

Buenos Aires , Argentina; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Córdoba, Argentina; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

San Isidro, Argentina; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Tucuman, Argentina; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Parkville, Australia; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Bruxelles, Belgium; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Liege, Belgium; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Rio De Janeiro, Brazil; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Sao Paulo, Brazil; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Sorocaba, Brazil; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Montreal, QC, Canada; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Beijing, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Beijing, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Guangdong, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Guangzhou, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Guangzhou, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Hangzhou, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Jiangsu, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Nanjing, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Shanghai, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Shanghai, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Praha, Czech Republic; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Lille, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Lyon, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Paris, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Toulouse, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Aachen, Germany; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Berlin, Germany; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Athens, Greece; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Debrecen, Hungary; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Szeged, Hungary; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Padova, Italy; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Mexico City, Mexico; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

San Luis Potosi, Mexico; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Coimbra, Portugal; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Lisboa, Portugal; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Porto, Portugal; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Barcelona, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Malaga, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Sevilla, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Cambridge, United Kingdom; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Leeds, United Kingdom; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

London, United Kingdom; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.

Barquisimeto, Venezuela; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Caracas, Venezuela; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.